Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics
Nom du journal : Breast Cancer Res Treat
Année : 2019
Volume : 177
Page de départ : 383
Page de fin : 393